# GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation

> **NCT01813435** · PHASE3 · COMPLETED · sponsor: **ECRI bv** · enrollment: 15991 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Acetylsalicylic Acid
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT01813435
- **Lead sponsor:** ECRI bv
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-01
- **Primary completion:** 2015-11-09
- **Final completion:** 2018-04-26
- **Target enrollment:** 15991 (ACTUAL)
- **Last updated:** 2022-03-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01813435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01813435, "GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01813435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*